LY294002 - Eli Lilly
Integrated multi-omics analysis identifies PI3K-Akt signaling as a candidate pathway in glufosinate-induced neurotoxicity. (PubMed, Neurotoxicology) - Sep 27, 2026 - "Quantitative PCR confirmed selected transcriptional changes related to cellular remodeling, while increased AKT phosphorylation together with a modest prolongation of the restricted mean seizure-free time following LY294002 treatment provided supportive evidence for the potential involvement of PI3K-Akt signaling. Collectively, this study provides a systems-level characterization of molecular responses to acute GLA exposure and highlights PI3K-Akt signaling as a candidate pathway for future mechanistic investigation." 
Journal • CNS Disorders • Epilepsy
http://www.ncbi.nlm.nih.gov/pubmed/42800587
 
Aihua Peng; Lili Chu; Shiyuan Tang; Tingyuan Zhou; Wen Ma; Xinjie Xiang; Xuxin Xie; Yu Cao
 
Sep 27, 2026
 
Prev Next